| P50 | author | Andrea Padoan | Q56605907 |
| | Giuseppe Basso | Q56810716 |
| | Sara Teolato | Q57252419 |
| | Carlo-Federico Zambon | Q57252421 |
| | Massimo Falconi | Q37378032 |
| | Gianpietro Semenzato | Q42574068 |
| P2093 | author name string | Chiara Frasson | |
| | Paolo Pederzoli | |
| | Monica Facco | |
| | Claudio Pasquali | |
| | Paola Fogar | |
| | Daniela Basso | |
| | Eliana Greco | |
| | Filippo Navaglia | |
| | Cosimo Sperti | |
| | Sergio Pedrazzoli | |
| | Dania Bozzato | |
| | Elisa Fadi | |
| | Stefania Moz | |
| | Domenico Tamburrino | |
| | Giuseppe De Franchis | |
| | Michela Pelloso | |
| | Elisa Gnatta | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 | Q24634871 |
| | Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 |
| | Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 |
| | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 |
| | Cancer statistics, 2010 | Q27860525 |
| | Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 |
| | Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 |
| | The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells | Q28299932 |
| | The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase | Q28507440 |
| | Pancreatic cancer | Q29616288 |
| | Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). | Q30534663 |
| | Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans | Q30976983 |
| | A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells | Q33335471 |
| | Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle | Q33351879 |
| | Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. | Q33723063 |
| | Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor | Q33728439 |
| | Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. | Q33733198 |
| | Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor | Q33805313 |
| | CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation | Q33849506 |
| | Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes | Q33978763 |
| | Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function | Q34087816 |
| | Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis | Q34102579 |
| | HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment | Q34243443 |
| | The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification | Q34321928 |
| | Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. | Q51803685 |
| | Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Q54287306 |
| | Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Q54421148 |
| | Immunology. Regulating suppression | Q56900368 |
| | Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer | Q61773591 |
| | Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer | Q73311980 |
| | CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma | Q75225386 |
| | Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer | Q81224928 |
| | Dynamics of the immune reaction to pancreatic cancer from inception to invasion | Q81381605 |
| | Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma | Q81383285 |
| | MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts | Q82414820 |
| | Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign | Q84256128 |
| | Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma | Q84425427 |
| | Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype | Q34406041 |
| | Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. | Q34898405 |
| | The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo | Q35118927 |
| | Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. | Q35222367 |
| | Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice | Q35370005 |
| | Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers | Q35497551 |
| | Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model | Q35516545 |
| | The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 |
| | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy | Q36108095 |
| | Role of immature myeloid cells in mechanisms of immune evasion in cancer | Q36208862 |
| | CTLA-4 is a second receptor for the B cell activation antigen B7 | Q36230356 |
| | Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. | Q36617328 |
| | Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. | Q36971755 |
| | Myeloid-derived suppressor cell role in tumor-related inflammation | Q37146806 |
| | Inhibitory B7-family molecules in the tumour microenvironment | Q37171804 |
| | Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. | Q37327260 |
| | Regulatory T cells in tumor immunity | Q37762224 |
| | Dendritic cells and immunity against cancer. | Q37821074 |
| | Cellular constituents of immune escape within the tumor microenvironment | Q38020632 |
| | Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8). | Q39666332 |
| | Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer | Q39981172 |
| | Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation | Q40124587 |
| | Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells | Q40241550 |
| | PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine | Q42839507 |
| | Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. | Q46529900 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e54824 | |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study | |
| P478 | volume | 8 | |